Meta‐analysis: the impact of oral anti‐viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B (Englisch)
- Neue Suche nach: Singal, A. K.
- Neue Suche nach: Salameh, H.
- Neue Suche nach: Kuo, Y.‐F.
- Neue Suche nach: Fontana, R. J.
- Neue Suche nach: Singal, A. K.
- Neue Suche nach: Salameh, H.
- Neue Suche nach: Kuo, Y.‐F.
- Neue Suche nach: Fontana, R. J.
In:
Alimentary Pharmacology & Therapeutics
;
38
, 2
;
98-106
;
2013
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:Meta‐analysis: the impact of oral anti‐viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B
-
Beteiligte:Singal, A. K. ( Autor:in ) / Salameh, H. ( Autor:in ) / Kuo, Y.‐F. ( Autor:in ) / Fontana, R. J. ( Autor:in )
-
Erschienen in:Alimentary Pharmacology & Therapeutics ; 38, 2 ; 98-106
-
Verlag:
-
Erscheinungsdatum:01.07.2013
-
Format / Umfang:9 pages
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Datenquelle:
Inhaltsverzeichnis – Band 38, Ausgabe 2
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 77
-
Review article: strategies for the management of chronic unremitting ulcerative colitisMehta, S. J. / Silver, A. R. / Lindsay, J. O. et al. | 2013
- 98
-
Meta‐analysis: the impact of oral anti‐viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis BSingal, A. K. / Salameh, H. / Kuo, Y.‐F. / Fontana, R. J. et al. | 2013
- 107
-
Randomised clinical trial: arbaclofen placarbil in gastro‐oesophageal reflux disease – insights into study design for transient lower sphincter relaxation inhibitorsVakil, N. B. / Huff, F. J. / Cundy, K. C. et al. | 2013
- 118
-
Durability of SVR in chronic hepatitis C patients treated with peginterferon‐α2a/ribavirin in combination with a direct‐acting anti‐viralRutter, K. / Hofer, H. / Beinhardt, S. / Dulic, M. / Gschwantler, M. / Maieron, A. / Laferl, H. / Stättermayer, A. F. / Scherzer, T.‐M. / Strassl, R. et al. | 2013
- 124
-
Health‐related quality of life in genotype 1 treatment‐naïve chronic hepatitis C patients receiving telaprevir combination treatment in the ADVANCE studyVera‐Llonch, M. / Martin, M. / Aggarwal, J. / Donepudi, M. / Bayliss, M. / Goss, T. / Younossi, Z. et al. | 2013
- 134
-
Vitamin E and changes in serum alanine aminotransferase levels in patients with non‐alcoholic steatohepatitisHoofnagle, J. H. / Van Natta, M. L. / Kleiner, D. E. / Clark, J. M. / Kowdley, K. V. / Loomba, R. / Neuschwander‐Tetri, B. A. / Sanyal, A. J. / Tonascia, J. / the Non‐alcoholic Steatohepatitis Clinical Research Network (NASH CRN) et al. | 2013
- 144
-
Natural history of acute upper GI bleeding due to tumours: short‐term success and long‐term recurrence with or without endoscopic therapySheibani, S. / Kim, J. J. / Chen, B. / Park, S. / Saberi, B. / Keyashian, K. / Buxbaum, J. / Laine, L. et al. | 2013
- 151
-
Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitisVarela, E. / Manichanh, C. / Gallart, M. / Torrejón, A. / Borruel, N. / Casellas, F. / Guarner, F. / Antolin, M. et al. | 2013
- 162
-
Young adults with coeliac disease may be at increased risk of early atherosclerosisDe Marchi, S. / Chiarioni, G. / Prior, M. / Arosio, E. et al. | 2013
- 170
-
Functional dyspepsia: the economic impact to patientsLacy, B. E. / Weiser, K. T. / Kennedy, A. T. / Crowell, M. D. / Talley, N. J. et al. | 2013
- 178
-
Cyclo‐oxygenase‐2 inhibitors or nonselective NSAIDs plus gastroprotective agents: what to prescribe in daily clinical practice?Masclee, G. M. C. / Valkhoff, V. E. / van Soest, E. M. / Schade, R. / Mazzaglia, G. / Molokhia, M. / Trifirò, G. / Goldstein, J. L. / Hernández‐Díaz, S. / Kuipers, E. J. et al. | 2013
- 190
-
Indirect comparison of randomised controlled trials: comparative efficacy of dexlansoprazole vs. esomeprazole in the treatment of gastro‐oesophageal reflux diseaseWu, M. S. / Tan, S. C. / Xiong, T. et al. | 2013
- 202
-
Commentary: revisiting the past – does it hold the key to the future treatment of refractory GERD?Katz, P. O. / Schnoll‐Sussman, F. et al. | 2013
- 203
-
Commentary: revisiting the past – does it hold the key to the future treatment of refractory GERD? Author's replyFox, M. et al. | 2013
- 204
-
Commentary: overcoming antibiotic resistance with Helicobacter pylori therapy – optimisation is the way forwardMolina‐Infante, J. / Gisbert, J. P. et al. | 2013
- 205
-
Commentary: overcoming antibiotic resistance with Helicobacter pylori therapy – optimisation is the way forward; authors' replySierra, F. / Forero, J. D. / Rey, M. / Botero, M. L. / Cárdenas, A. et al. | 2013
- 207
-
Letter: mucosal healing in ulcerative colitis – higher relevance than in Crohn's disease?Barreiro‐de Acosta, M. / Gisbert, J. P. et al. | 2013
- 208
-
Letter: lansoprazole consumption is more common in Japanese patients with collagenous colitisUmeno, J. / Esaki, M. / Nuki, Y. / Kim, H. / Kitazono, T. / Matsumoto, T. et al. | 2013
- 208
-
Letter: mucosal healing in ulcerative colitis – higher relevance than in Crohn's disease? Authors' replyLaharie, D. / Filippi, J. / Roblin, X. / Nancey, S. / Peyrin‐Biroulet, L. et al. | 2013
- 209
-
Letter: lansoprazole consumption is more common in Japanese patients with collagenous colitis – authors’ replyKeszthelyi, D. / Masclee, A. A. et al. | 2013
- 211
-
Corrigendum| 2013